188 related articles for article (PubMed ID: 28628016)
1. [ANTIRETROVIRAL THERAPY AND THE RISK OF LIVER FIBROSIS PROGRESSION IN HIV/HCV COINFECTED PATIENTS].
Arystanbekova M; Balmasova I; Malova E; Sepiashvili R
Georgian Med News; 2017 May; (266):58-63. PubMed ID: 28628016
[TBL] [Abstract][Full Text] [Related]
2. Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C virus-coinfected patients?
Verma S; Wang CH; Govindarajan S; Kanel G; Squires K; Bonacini M
Clin Infect Dis; 2006 Jan; 42(2):262-70. PubMed ID: 16355339
[TBL] [Abstract][Full Text] [Related]
3. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M
PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964
[TBL] [Abstract][Full Text] [Related]
4. HIV/hepatitis C coinfection natural history and disease progression.
Hernandez MD; Sherman KE
Curr Opin HIV AIDS; 2011 Nov; 6(6):478-82. PubMed ID: 22001892
[TBL] [Abstract][Full Text] [Related]
5. Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy.
Fuster D; Planas R; Muga R; Ballesteros AL; Santos J; Tor J; Sirera G; Guardiola H; Salas A; Cabré E; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1293-7. PubMed ID: 15650421
[TBL] [Abstract][Full Text] [Related]
6. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C
HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909
[TBL] [Abstract][Full Text] [Related]
7. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy.
Benhamou Y; Di Martino V; Bochet M; Colombet G; Thibault V; Liou A; Katlama C; Poynard T;
Hepatology; 2001 Aug; 34(2):283-7. PubMed ID: 11481613
[TBL] [Abstract][Full Text] [Related]
9. Advances in the management of HIV/HCV coinfection.
Mandorfer M; Schwabl P; Steiner S; Reiberger T; Peck-Radosavljevic M
Hepatol Int; 2016 May; 10(3):424-35. PubMed ID: 26758592
[TBL] [Abstract][Full Text] [Related]
10. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
Mehta SH; Thomas DL; Torbenson M; Brinkley S; Mirel L; Chaisson RE; Moore RD; Sulkowski MS
Hepatology; 2005 Jan; 41(1):123-31. PubMed ID: 15619237
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients.
Braun DL; Rauch A; Durisch N; Eberhard N; Anagnostopoulos A; Ledergerber B; Metzner KJ; Böni J; Weber R; Fehr J
HIV Med; 2014 Nov; 15(10):625-30. PubMed ID: 24894776
[TBL] [Abstract][Full Text] [Related]
12. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
13. Early initiation of antiretroviral therapy: the current best way to reduce liver-related deaths in HIV/hepatitis C virus-coinfected patients.
Shafran SD
J Acquir Immune Defic Syndr; 2007 Apr; 44(5):551-6. PubMed ID: 17224846
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in liver fibrosis and hepatitis C virus-related parameters in patients coinfected with human immunodeficiency virus.
Collazos J; Cartón JA; Asensi V
Curr HIV Res; 2011 Jul; 9(5):339-45. PubMed ID: 21827383
[TBL] [Abstract][Full Text] [Related]
15. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
Loko MA; Bani-Sadr F; Winnock M; Lacombe K; Carrieri P; Neau D; Morlat P; Serfaty L; Dabis F; Salmon D;
J Viral Hepat; 2011 Jul; 18(7):e307-14. PubMed ID: 21692942
[TBL] [Abstract][Full Text] [Related]
16. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.
Mohsen AH; Easterbrook PJ; Taylor C; Portmann B; Kulasegaram R; Murad S; Wiselka M; Norris S
Gut; 2003 Jul; 52(7):1035-40. PubMed ID: 12801963
[TBL] [Abstract][Full Text] [Related]
17. Management of hepatitis C virus coinfection in HIV-infected persons.
O'Leary JG; Chung RT
AIDS Read; 2006 Jun; 16(6):313-6, 318-20. PubMed ID: 16795921
[TBL] [Abstract][Full Text] [Related]
18. Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon.
McGovern BH; Birch C; Zaman MT; Bica I; Stone D; Quirk JR; Davis B; Zachary K; Basgoz N; Graeme-Cook F; Gandhi RT
Clin Infect Dis; 2007 Nov; 45(10):1386-92. PubMed ID: 17968840
[TBL] [Abstract][Full Text] [Related]
19. Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.
Sanmartin R; de Felipe E; Tor J; Sanvicens A; Barluenga E; Martinez E; Muga R; Jou A; Ojanguren I; López JJ; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1235-43. PubMed ID: 22443303
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of APRI score in liver disease following the introduction of antiretroviral therapy in HIV and HCV coinfected versus HIV monoinfected patients].
Antonello VS; Tovo CV; Kliemann DA; Santos BR; Zaltron VF
Rev Soc Bras Med Trop; 2010; 43(6):678-81. PubMed ID: 21181022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
